(Q34293369)

1 August 2017

title

Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial (English)

1 reference

1 August 2017

1 reference

1 reference

1 reference

4

Peter Libby

1 reference

1 August 2017

1

Paul M Ridker

1 reference

1 August 2017

5

Robert J Glynn

1 reference

1 August 2017

3

Jean G MacFadyen

1 reference

1 August 2017

2

Aruna Pradhan

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 August 2012

1 reference

1 August 2017

1 reference

1 August 2017

volume

380

1 reference

1 August 2017

issue

9841

1 reference

1 August 2017

page(s)

565-571

1 reference

Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3774022

Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3774022

Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3774022

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3774022

Statin therapy and risk of developing type 2 diabetes: a meta-analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3774022

A randomized trial of rosuvastatin in the prevention of venous thromboembolism

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3774022

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3774022

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3774022

Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3774022

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3774022

Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3774022

10.1016/S0140-6736(12)61190-8

28 October 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference

1 August 2017

1 reference